We’re on the forefront of Asthma detection and management technology

When dealing with asthma, there are many variables that make it difficult to know the severity of your case. An accurate measure of your airway inflammation can significantly improve the effectiveness of your therapy for asthma. With the Insight eNO System from Apieron, the newest breakthrough in asthma determination and management found at all the offices of Dr. Lubitz, we can now see what other current methods miss. The Insight eNO System - the only non-invasive biomarker on the market - provides an accurate measurement of airway inflammation, and provides results in less than a minute.

eNO (exhaled nitric oxide) has been established as a reliable marker of airway inflammation in asthma for over 10 years. Current methods in use to diagnose, monitor and manage asthma do not measure airway inflammation. Physician office measurement of eNO is a breakthrough in medical technology that provides physicians with a reliable tool to measure airway inflammation as an adjunct to the current diagnostic measures, e.g. lung function.